Skip to main content
IDEX Biometrics ASA logo

IDEX Biometrics ASA — Investor Relations & Filings

Ticker · IDEX ISIN · NO0013107490 LEI · 5967007LIEEXZXHECW11 OL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 1,330 across all filing types
Latest filing 2019-02-27 Capital/Financing Update
Country NO Norway
Listing OL IDEX

About IDEX Biometrics ASA

https://www.idexbiometrics.com/

IDEX Biometrics ASA is a technology company specializing in fingerprint identification and biometric authentication solutions. The company designs, develops, and commercializes proprietary fingerprint sensors and software for integration into smart cards. Its core products are biometric payment cards and access cards, which provide enhanced security for financial transactions and identity verification. The technology stores and matches the user's fingerprint data directly on the card, ensuring that sensitive biometric information is never stored in the cloud. This on-card approach enables secure and convenient authentication with a simple touch, replacing traditional PINs and passwords. The solutions are certified by major payment networks like Visa and Mastercard and are compliant with FIDO standards for strong online authentication, offering protection against phishing and other cyber threats for both payment and access control systems.

Recent filings

Filing Released Lang Actions
Registration of share capital increase in IDEX
Capital/Financing Update Classification · 98% confidence The document explicitly discusses the 'Registration of share capital increase' following a private placement, detailing the new total share capital and the number of shares. This directly relates to changes in the company's capital structure. Based on the definitions, 'Capital/Financing Update' (CAP) is the most appropriate classification, as it covers updates on capital structure changes. The document length (1406 chars) is short, but the content is a definitive announcement of a capital structure event, not merely an announcement *about* a report, making CAP more specific than RPA or RNS.
2019-02-27 English
IDEX ASA - Fourth quarter and preliminary year-end 2018 results
Investor Presentation Classification · 99% confidence The document text provides a detailed review of 'Fourth quarter and recent highlights,' discusses 'Outlook and expected upcoming milestones,' outlines the company's strategy, details technological advantages (off-chip technology), mentions global partnerships, and concludes with a summary and outlook, referencing specific dates like 'Oslo, 26 February 2019' and financial events like a funding round completed on '30 January 2019'. This structure strongly suggests a comprehensive report covering a full fiscal period (Q4) and the year's performance, which aligns best with an Annual Report (10-K) or a detailed Interim/Quarterly Report (IR). Since the text explicitly mentions 'Fourth quarter' highlights and provides a forward-looking statement for the year ('significant revenue growth in 2019'), it is a comprehensive period report. Given the depth and the year-end focus, it is most likely an Annual Report (10-K) or a very detailed Quarterly Report (IR). Since it covers the fourth quarter and recent highlights, and is not explicitly labeled as a 10-K filing, the most appropriate classification for a comprehensive period report that is not the full annual filing is Interim/Quarterly Report (IR). However, the content is very detailed, covering strategy and technology roadmap, which often accompanies an Annual Report. Given the date (Feb 2019) and the focus on Q4, it is likely a year-end report, but without explicit 10-K headers, IR is safer for a comprehensive period review. If this were an earnings release (ER), it would be much shorter and focus only on key numbers. This document reads like the narrative section accompanying financial results for the year/Q4. I will classify it as an Interim/Quarterly Report (IR) as it details Q4 performance and outlook, which is typical for a year-end IR if the 10-K has not yet been filed, or it could be the Management Discussion & Analysis (MDA) section of a larger report. Given the comprehensive nature covering strategy, technology, and operational highlights following a Q4 period, IR is the best fit among the provided options for a detailed period report.
2019-02-27 English
IDEX ASA - Fourth quarter and preliminary year-end 2018 results
Investor Presentation Classification · 99% confidence The document is titled '4 TH QUARTER 2018 PRESENTATION' and includes sections like 'CEO, Stan Swearingen CFO, Henrik Knudtzon', 'FUNDAMENTAL ATTRACTIONS OF BIOMETRIC PAYMENT CARDS', and a 'FINANCIAL UPDATE' section led by the CFO. It discusses business strategy, product roadmaps, market positioning, and financial outlook (cost control, cash flow, revenue opportunities) related to Q4 2018 performance. This structure strongly indicates an Investor Presentation or a presentation accompanying an earnings release, but since it is a detailed presentation deck format rather than a formal press release summary, 'Investor Presentation' (IP) is the most appropriate classification. It is not a full 10-K, a formal Earnings Release (ER) press release, or a Call Transcript (CT).
2019-02-27 English
IDEX ASA - Fourth quarter and preliminary year-end 2018 results
Earnings Release Classification · 100% confidence The document is titled "IDEX ASA - Fourth quarter and preliminary year-end 2018 results" and contains highlights, commentary from the CEO, and financial position updates for the fourth quarter and full year 2018. This content structure strongly suggests an Earnings Release (ER) or an Interim/Quarterly Report (IR). However, the text explicitly mentions that the company is "hosting a presentation of the results today" and concludes with the statement: "Please find the fourth quarter 2017 report and the presentation of the results attached or linked at the end of this notice." The document itself is a summary announcement of the results, not the comprehensive report (which is referenced as attached/linked). Furthermore, the length (4754 chars) is typical for a brief announcement. Therefore, it is classified as an Earnings Release (ER) as it announces the period's results. Q4 2018
2019-02-27 English
IDEX ASA: Grant of Incentive Subscription Rights in IDEX
Remuneration Information Classification · 99% confidence The document announces the grant of 873,800 incentive subscription rights to employees and contractors by the board of directors of IDEX ASA. This action directly relates to the company's capital structure, employee compensation/incentives, and share issuance mechanisms. This fits best under the 'Capital/Financing Update' (CAP) category, as it involves the issuance of rights that will ultimately lead to new shares, or potentially 'Share Issue/Capital Change' (SHA). However, since it is specifically about incentive rights/options granted, which is a form of capital management/financing activity, CAP is a strong fit. It is not a general earnings release (ER), a full annual report (10-K), or a director's dealing (DIRS). Given the context of granting rights that affect future capital, CAP is the most precise fit among the options provided, although SHA is also closely related. I will select CAP as it covers financing activities.
2019-02-27 English
IDEX ASA: Mandatory Notice of Trade in IDEX - Incentive Subscription
Director's Dealing Classification · 100% confidence The document explicitly details a transaction involving shares/rights by a director ('Stuart Hunt, Director of Investor Relations & Communication') within IDEX ASA. The title mentions 'Mandatory Notice of Trade in IDEX - Incentive Subscription'. This directly aligns with the definition of Director's Dealing (insider trades) as defined by the filing types. The code for this is DIRS.
2019-02-27 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.